Back to Search
BYRON KAM, PHARMD
PHARMD
Pharmacist
NPI: 1477118628Individual
Specialties, Licenses & Credentials
Research & Publications (18)
Peptide-receptor radionuclide therapy for endocrine tumors.
PMID 19488074·Nat Rev Endocrinol·2009
6-review
Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours.
PMID 18188559·Eur J Nucl Med Mol Imaging·2008
8-other
Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.
PMID 18445841·J Clin Oncol·2008
2-rct
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.
PMID 18210106·Eur J Nucl Med Mol Imaging·2008
8-other
Hybrid external fixation of proximal tibia fractures: biomechanical analysis of four commercial systems.
PMID 18198775·Orthopedics·2007
4-observational
Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues.
PMID 17548040·Hematol Oncol Clin North Am·2007
6-review
Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?
PMID 17015911·J Nucl Med·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 316 S PACIFIC COAST HWY
REDONDO BEACH, CA 90277 - Phone
- (310) 540-9183
Quick Facts
- NPI
- 1477118628
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile